Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Manuscript
  • Published:

Quantification of minimal residual disease in patients with e1a2 BCR-ABL-positive acute lymphoblastic leukemia using a real-time RT-PCR assay

Abstract

Using a real-time RT-PCR method, we analyzed the expression of e1a2 BCR-ABL mRNA in bone marrow samples from 13 patients with e1a2 BCR-ABL-positive acute lymphoblastic leukemia (ALL) at different time points during chemotherapy and after bone marrow transplantation (BMT). The detection limit of the method, assessed using serial dilutions of ALL/MIK cells, was found to be 1:105, similar to what is observed for the conventional RT-nested PCR method. The e1a2 BCR-ABL values were normalized with respect to those of the housekeeping gene GAPDH. The decrease in the e1a2 BCR-ABL/GAPDH ratio after remission induction chemotherapy reflects well the response to chemotherapy and consequently correlates with the prognosis. Although molecular remission was achieved by chemotherapy alone, some patients relapsed, and the e1a2 BCR-ABL/GAPDH ratios in these cases progressively increased to the levels seen prior to hematological relapse. Long-term hematological complete remission (more than 30 months) could be achieved in cases in which a more than 4.0 log decrease in the e1a2 BCR-ABL/GAPDH ratio was obtained by chemotherapy alone, and BMT was then performed. In conclusion, real-time RT-PCR allows for an evaluation of the kinetics of e1a2 BCR-ABL/GAPDH expression during the various phases of chemotherapy or after BMT and may be effective for the indication and control of disease relapse in Ph-positive ALL patients.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  1. Hermans A, Heisterkamp N, von Lindern M, van Baal S, Meijer D, van der Plas D, Wiedemann LM, Groffen J, Bootsma D, Grosveld G . Unique fusion of bcr and c-abl genes in Philadelphia chromosome positive acute lymphoblastic leukemia Cell 1987 51: 33–40

    Article  CAS  Google Scholar 

  2. Clark SS, McLaughlin J, Timmons M, Pendergast AM, Ben-Neriah Y, Dow LW, Crist W, Rovera G, Smith SD, Witte ON . Expression of a distinctive BCR-ABL oncogene in Ph-positive acute lymphocytic leukemia (ALL) Science 1988 239: 775–777

    Article  CAS  Google Scholar 

  3. Schaefer-Rego K, Arlin Z, Shapiro LG, Mears JG, Leibowitz D . Molecular heterogeneity of adult Philadelphia chromosome-positive acute lymphoblastic leukemia Cancer Res 1988 48: 866–869

    CAS  Google Scholar 

  4. Bloomfield CD, Goldman AI, Alimena G, Berger R, Borgstrom GH, Brandt L, Catovsky D, de la Chapelle A, Dewald GW, Garson OM, Garwicz S, Golomb HM, Hossfeld DK, Lawler SD, Mitelman F, Nilsson P, Pierre RV, Philip P, Prigogina E, Rowely JD, Sakurai M, Sandberg AA, Secker-Walker LM, Tricot G, Van Den Berghe H, Van Orshoven A, Vuopio P, Whang-Peng J . Chromosomal abnormalities identify high-risk and low-risk patients with acute lymphoblastic leukemia Blood 1986 67: 415–420

    CAS  Google Scholar 

  5. Fenaux P, Lai JL, Morel P, Nelken B, Taboureau O, Deminatti M, Bauters F . Cytogenetics and their prognostic value in childhood and adult acute lymphoblastic leukemia (ALL) excluding L3 Hematol Oncol 1989 7: 307–317

    Article  CAS  Google Scholar 

  6. Secker-Walker LM, Craig JM, Hawkins JM, Hoffbrand AV . Philadelphia positive acute lymphoblastic leukemia in adults: age distribution, BCR breakpoint and prognostic significance Leukemia 1991 5: 196–199

    CAS  Google Scholar 

  7. Westbrook CA, Hooberman AL, Spino C, Dodge RK, Larson RA, Davey F, Wurster-Hill DH, Sobol RE, Schiffer C, Bloomfield CD . Clinical significance of the BCR-ABL fusion gene in adult acute lymphoblastic leukemia: a Cancer and Leukemia Group B Study (8762) Blood 1992 80: 2983–2990

    CAS  Google Scholar 

  8. Maurer J, Janssen JW, Thiel E, van Denderen J, Ludwig WD, Aydemir U, Heinze B, Fonatsch C, Harbott J, Reiter A, Riehm H, Hoelzer D, Bartram CR . Detection of chimeric BCR-ABL genes in acute lymphoblastic leukaemia by the polymerase chain reaction Lancet 1991 337: 1055–1058

    Article  CAS  Google Scholar 

  9. Kurzrock R, Shtalrid M, Romero P, Kloetzer WS, Talpaz M, Trujillo JM, Blick M, Beran M, Gutterman JU . A novel c-abl protein product in Philadelphia-positive acute lymphoblastic leukaemia Nature 1987 325: 631–635

    Article  CAS  Google Scholar 

  10. Fainstein E, Marcelle C, Rosner A, Canaani E, Gale RP, Dreazen O, Smith SD, Croce CM . A new fused transcript in Philadelphia chromosome positive acute lymphocytic leukaemia Nature 1987 330: 386–388

    Article  CAS  Google Scholar 

  11. Kawasaki ES, Clark SS, Coyne MY, Smith SD, Champlin R, Witte ON, McCormick FP . Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro Proc Natl Acad Sci USA 1988 85: 5698–5702

    Article  CAS  Google Scholar 

  12. Kurzrock R, Gutterman JU, Talpaz M . The molecular genetics of Philadelphia chromosomepositive leukemias N Engl J Med 1988 319: 990–998

    Article  CAS  Google Scholar 

  13. Kantarjian HM, Talpaz M, Dhingra K, Estey E, Keating MJ, Ku S, Trujillo J, Huh Y, Stass S, Kurzrock R . Significance of the P210 versus P190 molecular abnormalities in adults with Philadelphia chromosome-positive acute leukemia Blood 1991 78: 2411–2418

    CAS  Google Scholar 

  14. Radich JP, Kopecky KJ, Boldt DH, Head D, Slovak ML, Babu R, Kirk J, Lee A, Kessler P, Appelbaum F, Gehly G . Detection of BCR-ABL fusion genes in adult acute lymphoblastic leukemia by the polymerase chain reaction Leukemia 1994 8: 1688–1695

    CAS  Google Scholar 

  15. Schlieben S, Borkhardt A, Reinisch I, Ritterbach J, Janssen JW, Ratei R, Schrappe M, Repp R, Zimmermann M, Kabisch H, Janka-Schaub G, Bartram CR, Ludwig WD, Riehm H, Lampert F, Harbott J . Incidence and clinical outcome of children with BCR/ABL-positive acute lymphoblastic leukemia (ALL). A prospective RT-PCR study based on 673 patients enrolled in the German pediatric multicenter therapy trials ALL-BFM-90 and CoALL-05–92 Leukemia 1996 10: 957–963

    CAS  Google Scholar 

  16. Hoelzer D, Thiel E, Loeffler H, Bodenstein H, Plaumann L, Buechner T, Urbanitz D, Koch P, Heimpel H, Engelhardt R, Mueller U, Wendt FC, Sodomann H, Ruehl H, Herrmann F, Kaboth W, Dietzfelbinger H, Pralle H, Lunscken C, Hellriegel KP, Spors S, Nowrousian RM, Fischer J, Fuelle H, Mitrou PS, Pfreundschuh M, Goerg C, Emmerich B, Queisser W, Meyer P, Labedzki L, Essers U, Koenig H, Mainzer K, Herrmann R, Messerer D, Zwingers T . Intensified therapy in acute lymphoblastic and acute undifferentiated leukemia in adults Blood 1984 64: 38–47

    CAS  Google Scholar 

  17. Hoelzer D . Treatment of acute lymphoblastic leukemia Semin Hematol 1994 31: 1–15

    CAS  Google Scholar 

  18. Miyamura K, Tanimoto M, Morishima Y, Horibe K, Yamamoto K, Akatsuka M, Kodera Y, Kojima S, Matsuyama K, Hirabayashi N, Yazaki M, Imai K, Onozawa Y, Kanamaru A, Mizutani S, Saito H . Detection of Philadelphia chromosome-positive acute lymphoblastic leukemia by polymerase chain reaction: possible eradication of minimal residual disease by marrow transplantation Blood 1992 79: 1366–1370

    CAS  Google Scholar 

  19. Barrett AJ, Horowitz MM, Ash RC, Atkinson K, Gale RP, Goldman JM, Henslee-Downey PJ, Herzig RH, Speck B, Zwaan FE, Bortin MM . Bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia Blood 1992 79: 3067–3070

    CAS  Google Scholar 

  20. Chao NJ, Blume KG, Forman SJ, Snyder DS . Long-term follow-up of allogeneic bone marrow recipients for Philadelphia chromosome-positive acute lymphoblastic leukemia Blood 1995 85: 3353–3354

    CAS  Google Scholar 

  21. Gehly GB, Bryant EM, Lee AM, Kidd PG, Thomas ED . Chimeric BCR-abl messenger RNA as a marker for minimal residual disease in patients transplanted for Philadelphia chromosome-positive acute lymphoblastic leukemia Blood 1991 78: 458–465

    CAS  Google Scholar 

  22. Mitterbauer G, Fodinger M, Scherrer R, Knobl P, Jager U, Laczika K, Schwarzinger I, Gaiger A, Geissler K, Greinix H, Kalhs P, Linkesch W, Lechner K . Mannhalter C. PCR-monitoring of minimal residual leukaemia after conventional chemotherapy and bone marrow transplantation in BCR-ABL-positive acute lymphoblastic leukaemia Br J Haematol 1995 89: 937–941

    Article  CAS  Google Scholar 

  23. Preudhomme C, Henic N, Cazin B, Lai JL, Bertheas MF, Vanrumbeke M, Lemoine F, Jouet JP, Deconninck E, Nelken B, Cosson A, Fenaux P . Good correlation between RT-PCR analysis and relapse in Philadelphia (Ph1)-positive acute lymphoblastic leukemia (ALL) Leukemia 1997 11: 294–298

    Article  CAS  Google Scholar 

  24. Sierra J, Radich J, Hansen JA, Martin PJ ., Petersdorf EW, Bjerke J, Bryant E, Nash RA, Sanders JE, Storb R, Sullivan KM, Appelbaum FR, Anasetti C. Marrow transplants from unrelated donors for treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia Blood 1997 90: 1410–1414

    CAS  Google Scholar 

  25. Radich J, Gehly G, Lee A, Avery R, Bryant E, Edmands S, Gooley T, Kessler P, Kirk J, Ladne P, Thomas ED, Appelbaum FR . Detection of bcr-abl transcripts in Philadelphia chromosome-positive acute lymphoblastic leukemia after bone marrow transplantation Blood 1997 89: 2602–2609

    CAS  Google Scholar 

  26. van Rhee F, Marks DI, Lin F, Szydlo RM, Hochhaus A, Treleaven J, Delord C, Cross NC, Goldman JM . Quantification of residual disease in Philadelphia-positive acute lymphoblastic leukemia: comparison of blood and bone marrow Leukemia 1995 9: 329–335

    CAS  Google Scholar 

  27. Mitterbauer G, Nemeth P, Wacha S, Cross NC, Schwarzinger I, Jaeger U, Geissler K, Greinix HT, Kalhs P, Lechner K, Mannhalter C . Quantification of minimal residual disease in patients with BCR-ABL-positive acute lymphoblastic leukaemia using quantitative competitive polymerase chain reaction Br J Haematol 1999 106: 634–643

    Article  CAS  Google Scholar 

  28. Higa T, Okabe M, Kunieda Y, Kodama S, Itaya T, Kurosawa M, Sakurada K, Maekawa I, Shoji M, Kasai M, Miyazaki T . Establishment and characterization of a new Ph1-positive ALL cell line (ALL/MIK) presenting bcr gene rearrangement on bcr-2 and ALL-type bcr/abl transcript: suggestion of in vitro differentiation to monocytoid lineage Leuk Lymphoma 1994 12: 287–96

    Article  CAS  Google Scholar 

  29. Koeffler HP, Golde DW . Human myeloid leukemia cell lines: a review Blood 1980 56: 344–350

    CAS  Google Scholar 

  30. Martin H, Atta J, Bruecher J, Elsner S, Schardt C, Stadler M, von Melchner H, Hoelzer D . In patients with BCR-ABL-positive ALL in CR peripheral blood contains less residual disease than bone marrow: implications for autologous BMT Ann Hematol 1994 68: 85–87

    Article  CAS  Google Scholar 

  31. Elmaagacli AH, Beelen DW, Opalka B, Seeber S, Schaefer UW . The amount of BCR-ABL fusion transcripts detected by the real-time quantitative polymerase chain reaction method in patients with Philadelphia chromosome positive chronic myeloid leukemia correlates with the disease stage Ann Hematol 2000 79: 424–431

    Article  CAS  Google Scholar 

  32. Barbany G, Hagberg A, Olsson-Stromberg U, Simonsson B, Syvanen AC, Landegren U . Manifold-assisted reverse transcription-PCR with real-time detection for measurement of the BCR-ABL fusion transcript in chronic myeloid leukemia patients Clin Chem 2000 46: 913–920

    CAS  Google Scholar 

  33. Druker BJ, Tamura S, Buchdunger E, Ohno S, Segal GM, Fanning S, Zimmermann J, Lydon NB . Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells Nat Med 1996 2: 561–566

    Article  CAS  Google Scholar 

  34. Kawaguchi Y, Jinnai I, Nagai K, Yagasaki F, Yakata Y, Matsuo T, Kuriyama K, Tomonaga M . Effect of a selective Abl tyrosine kinase inhibitor, STI571, on in vitro growth of BCR-ABL-positive acute lymphoblastic leukemia cells Leukemia 2001 15: 590–594

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Mrs Emiko Takahashi, Mr Ryoichi Saito and Mr Junichi Hayakawa for their excellent technical assistance.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yokota, H., Tsuno, N., Tanaka, Y. et al. Quantification of minimal residual disease in patients with e1a2 BCR-ABL-positive acute lymphoblastic leukemia using a real-time RT-PCR assay. Leukemia 16, 1167–1175 (2002). https://doi.org/10.1038/sj.leu.2402483

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2402483

Keywords

This article is cited by

Search

Quick links